Sage Therapeutics Inc. buy Piper Sandler
Start price
30.10.24
/
50%
€5.99
Target price
30.10.25
€23.94
Performance (%)
26.96%
End price
31.10.25
-
Summary
This prediction is currently being closed. The BUY prediction by Piper_Sandler currently has a performance of 26.96%. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
Comments by Piper_Sandler for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $26.00 price target on the stock, down previously from $52.00.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.63
02.01.25
02.01.25
€8.77
02.01.26
02.01.26
35.22%
03.01.26
03.01.26
